|
|
|
|
| Don't miss the next Cell & Gene Live discussion on how CAR-T manufacturing has advanced recently and where it's going. Host Tyler Menichiello welcomes CTMC's Jason Bock, Ph.D., Cartesian Therapeutics' Emily English, Ph.D., and former FDA-turned Dark Horse consultant and CMC Expert, Tal Salz, Ph.D., for this digital event happening Tuesday, August 27, at 11 AM ET. Registration is free thanks to the support of CPC. |
|
|
|
|
By Annie Lamontagne, Blake Bergam, and Uzma Shoukat-Mumtaz, Dark Horse Consulting | These recommendations guide cell and gene therapy companies in selecting innovative tools, technology, and services to ensure forward compatibility from early to later development stages. |
|
|
|
Panelists on the Cell & Gene Live event discuss the tasks and processes currently automated in the cell and gene therapy space, as well as how automation tech impacts job roles and skill requirements. |
|
|
|
|
| The Role Of Platform Processes In Cell Therapy | Webinar | BioCentriq | Learn how the streamlined processes and reduced complexity enabled by a platform approach can lead to scalable manufacturing, rapid delivery, and expanded patient access for cell therapies. |
|
|
|
|
| Setting Expectations For Post-Thaw Segment QC Testing On A CBU | Poster | Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises | Examine the post-thaw segment QC results for 2,249 consecutive segments cut at our institution, in order to create a benchmark of what is to be expected when interpreting segment testing. |
|
|
| A Continuous Electroporation System For Viral Gene Therapy | Article | By Takashi Yakushiji and Yoichi Nagai, FUJIFILM Diosynth Biotechnologies | Explore the development work involved for the individual technologies that make up an innovative and scalable, chemical-free continuous viral vector production platform. |
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
